The FDA has granted a fast track designation to the first-in-class nucleotide an
- This topic has 0 replies, 1 voice, and was last updated 2 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The FDA has granted a fast track designation to the first-in-class nucleotide analogue NUC-1031 (Acelarin)
https://www.onclive.com/view/fda-grants-fast-track-status-to-nuc-1031-for-biliary-tract-cancer
Thanks to OncLive for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.